MBIO:NASDAQ
Mustang Bio Inc
0,46Â USD
0,00%
(0,00) 1Â D
6. okt., 15:59:52 GMT-4 · USD
search
Alle symboler
| Symbol | Pris | Endring | Endring (%) |
|---|
insights_autoGenererer viktig statistikk for MBIO …
Markedsverdi
3,54Â mill.
Snittvolum
25,87k
Volum
84,00
52 u høy
1,85Â USD
52Â u lav
0,46Â USD
EPS
−0,46 USD
Beta
2,09
Utestående aksjer
6,73Â mill.
Antall ansatte
4
Markedsverdi
3,54Â mill.
Snittvolum
25,87k
Volum
84,00
52 u høy
1,85Â USD
52Â u lav
0,46Â USD
EPS
−0,46 USD
Beta
2,09
Utestående aksjer
6,73Â mill.
Antall ansatte
4
Nyhetssaker
Fra nettkilder og nyhetspartnere
AD HOC NEWS
·
for 11 timer siden
MBIO stock sits near its 52-week low as Nasdaq deadline nears
Profil
Mustang Bio is an American clinical-stage biopharmaceutical company founded in 2015 and headquartered in Worcester, MA, U.S. Operating as a partner company of Fortress Biotech, Mustang Bio develops CAR-T immunotherapies and gene therapies for multiple diseases, including hematologic cancers, solid tumors, and X-linked severe combined immunodeficiency. Wikipedia
Om Mustang Bio Inc
Administrerende direktørManuel Litchman
Ansatte4
Grunnlagt2015
HovedkontorWaltham, Massachusetts, USA
Sektor-
Nettstedmustangbio.com